Synthesis and Characterization of Copper Nanoparticles by Chemical Method Using Ascorbic acid as a Reducing Agent in Presence of Metronidazole Benzoate (MTZ.B) (1-(2-benzyloxy ethyl)-5-nitro methyl imidazole) Drug

Abstract

      Copper nanoparticles (Cu NPs) have synthesized via reduction of copper   (II) sulfate pentahydrate salt  (Cu SO₄ .5H₂O)  using ascorbic acid as reducing and polyvinyl pyrrolidone PVP (M.Wt 10,000) as a  stabilizing agents in presence of Metronidazole Benzoate (MTZ.B) (1-(2-benzyloxy ethyl)-5-nitro methyl imidazole) drug by chemical method. The resulting Cu NPs were characterized by "UV–Vis spectroscopy, atomic force microscopy (AFM), X-ray diffraction (XRD) and FT-IR spectroscopy".